Novel use of skin substitute as rescue therapy in complicated giant exomphalos

Journal of Pediatric Surgery
Sarah L AlmondPaul D Losty

Abstract

Giant exomphalos can be successfully managed using conservative or surgical techniques. However, if treatment is complicated by sepsis, early skin cover of the defect becomes necessary. Options include split skin grafting, but in the presence of ongoing infection the risk of graft failure is high and limited skin is available for regrafting. We describe the novel use of a skin substitute (Integra Artificial Skin, Integra Life Sciences Corporation, Plainsboro, NJ) as an alternative to primary grafting in the management of infected giant exomphalos.

References

May 1, 1987·American Journal of Surgery·E I Hatch, R Baxter
Jan 26, 2000·Journal of Pediatric Surgery·A Wakhlu, A K Wakhlu
Jul 14, 2001·Burns : Journal of the International Society for Burn Injuries·M BalasubramaniM Babu

❮ Previous
Next ❯

Citations

Nov 21, 2008·Seminars in Pediatric Surgery·Sean Marven, Anthony Owen
Mar 8, 2011·Journal of Pediatric Surgery·Floortje C van EijckRene M H Wijnen
Oct 27, 2015·Plastic and Reconstructive Surgery. Global Open·Jennifer GaonaAdriana Robayo

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.